MVP medical developments international limited

Continuous Flow technology

  1. 2,772 Posts.
    lightbulb Created with Sketch. 437
    We Continue to Pursue Longer term Opportunities

    Penthrox in the US
    •Positive exchange with FDA Type C meeting on January 21
    •Awaiting final ‘post meeting note’ regarding path forward

    Penthrox in China
    •Phase I Pharmaco Kinetic (PK) study protocol finalised; first patient to be enrolled in Q32021
    •Phase III Trauma study can commence following PK study first enrolment
    •Phase III Procedural study to commence in Q1 2022

    Continuous Flow technology
    •Advancements made in late stage Lidocaine scale up development
    •Plans to advance four additional active pharmaceutical ingredients (API) into scale upphase during 2021.

    MVP is on the cusp of greatness and with lots of cash in the bank ex CSL management buying lots of shares personally on market the past few months i am struggling to see better value and potential upside on the ASX.

    The continuous flow tech alone is worth multiple dollars per share not being priced in.

    Do some digging on this as i believe the first deal they do on Lidocaine manufacturing in which management states will safe between $400 and $500 million per year half of what MVP keeps... thats for 1 drug alone....

    Continuous Flow

    •Increasedyields –through better process conversion

    •Increasedpurity –through better process control

    •Bettercontrol over entire process –test in real time

    •Lower costof production

    •LowerCAPEX

    •Less waste

    •Lesscarbon footprint ‘greener technology’

    •Smallerfootprint

    •Quicker toscale-up

    •Safer

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
73.0¢
Change
-0.010(1.35%)
Mkt cap ! $82.24M
Open High Low Value Volume
74.0¢ 75.0¢ 71.0¢ $109.2K 149.3K

Buyers (Bids)

No. Vol. Price($)
1 714 70.0¢
 

Sellers (Offers)

Price($) Vol. No.
75.0¢ 40678 1
View Market Depth
Last trade - 16.10pm 13/08/2025 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.